Home Blog Page 4

Antibodies to squalene in Veterans

Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness

Abstract

Since the end of the 1991 Gulf War, there have been reports of unexplained, multisymptom illnesses afflicting veterans who consistently report more symptoms than do nondeployed veterans. One of the many
possible exposures suspected of causing chronic multisymptom illnesses Gulf War veterans is squalene,
thought to be present in anthrax vaccine. We examined the relationship between squalene antibodies
and chronic symptoms reported by Navy construction workers (Seabees), n = 579. 30.2% were deployers, 7.4% were defined as ill, and 43.5% were positive for squalene antibodies. We found no association
between squalene antibody status and chronic multisymptom illness (p = 0.465). The etiology of Gulf War
syndrome remains unknown, but should not include squalene antibody status.
Published by Elsevier Ltd

CLICK HERE TO OPEN PDF

Conclusion:

Although the Naval Health Research Center claims they found no correlation between Gulf War Syndrome and Squalene antibodies; Operation Truth will not simply accept this as an answer.  As a team, we believe that there is a connection between vaccine(s) and the veteran.  We believe that this yet unknown connection is why certain veterans are affected by such a deteriorating illness and others are not.  We will continue our research in this field and try to find a connection.

Anti Squalene Patent

Anti Squalene Patent

Apr 10th, 2001

Method for Detecting Anti-Squalene Antibodies for Gulf War Illness

Inventors:  Pamela Asa, and Robert Garry

CLICK HERE TO OPEN PDF

Symptoms of Gulf War Illness

Symptoms of Gulf War Illness

Do you or somebody you know that received the Anthrax Vaccine (or is a child of someone who had the vaccine) and has more than a handful of the symptoms of Gulf War Illness listed below?  If so you certainly are not alone and we are glad you have found us.

  • Aching Joints
  • Chronic Fatigue
  • Headaches
  • Memory Loss
  • Sleep Difficulties
  • Skin Rashes
  • Concentration Loss
  • Muscle Spasms
  • Depression
  • Nervousness
  • Diarrhea
  • Blurred Vision
  • Anxiety
  • Breathing Problems
  • Chest Pain

There is a close resemblance of these symptoms and those of a patient with Major Signs and Symptoms of Chronic Fatigue Syndrome and Fibromyalgia as seen below:

  • Chronic Fatigue
  • Depression
  • Paresthesia
  • Joint Pain / Reduced Mobility
  • Vision Problems / Light Sensitivity
  • Cognitive Problems
  • Muscle Spasms / Burning Muscles
  • Dizziness / Balance Disturbance
  • Stuttering / Difficulty Speaking
  • Breathing Problems
  • Flatulence / Bloating
  • Headache
  • Lack of Bladder Control
  • Chemical Sensitivities
  • Stomach Cramps or Pain

In addition, a good amount of Veterans seem to also suffer from neurological issues such as numbness, tingling, or shooting paint in certain parts of their body.

 

Credit:  Dr. Garth Nicholson http://www.immed.org/signsympt.htm

The Anthrax Vaccine Program

The Anthrax Vaccine Program

An Analysis of the CDC’s Recommendations for Vaccine Use

Abstract

The anthrax vaccine was never proved to be safe and effective. It is one cause of Gulf War illnesses, and recent vaccinees report symptoms resembling Gulf War illnesses.

The vaccine’s production has been substandard. Without adequate evaluation, the Food and Drug Administration recently approved (retrospectively) significant changes made to the vaccine’s composition since 1990. The vaccine’s mandatory use for inhalation anthrax is “off-label.”

A skewed review of the vaccine literature by the Centers for Disease Control and Prevention (CDC) led to remunerative collaborative research with the army, involving civilian volunteers. Despite acknowledging possible fetal harm, the CDC offered the vaccine to children and pregnant women.

New trends could weaken prelicensure efficacy and safety review of medical products intended for biodefense and avoid manufacturer liability for their use.

Full PDF:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447151/pdf/0920715.pdf

Total Force Anthrax Vaccine Immunization Program

Harvard Library 2001: Total Force Anthrax Vaccine Immunization Program Controversy and Conflagration

Author: Corrigan, Shara, L.

Full PDF:  https://dash.harvard.edu/bitstream/handle/1/8965604/Corrigan.pdf?sequence=1&isAllowed=y

Anthrax Vaccine Information Sheet

Anthrax Vaccine Information Sheet

World Health Organization 2012

The Anthrax Vaccine Information Sheet from the World Health Organization shows statistics of adverse reactions from the Anthrax Vaccine – 2012

Full PDF:  https://www.who.int/vaccine_safety/initiative/tools/Anthrax_Vaccine_rates_information_sheet.pdf

Local PDF: http://www.operationtruth.net/wp-content/uploads/articles/WHO Anthrax_Vaccine_rates_information_sheet.pdf

Research Advisory Committee on Gulf War Veterans’ Illnesses

Research Advisory Committee on Gulf War Veterans’ Illnesses

Gulf War Illness and the Health of Gulf War Veterans 2009-2013

Final Report FY: 2014

 

Full PDF:  https://www.va.gov/RAC-GWVI/RACReport2014Final.pdf

Types of Vaccine Adjuvants

Types of Vaccine Adjuvants

Efforts to develop safe and effective vaccines increasingly involve the use of adjuvants—substances formulated as part of a vaccine to boost immune responses and enhance the vaccine’s effectiveness. NIAID supports a broad portfolio of vaccine adjuvant research, ranging from basic immunology studies to clinical testing of adjuvanted vaccine candidates.

Vaccine adjuvants accelerate, enhance and prolong the immune responses triggered by antigens—the vaccine components that elicit pathogen-specific immune responses. Certain populations, such as people with compromised immune systems, the elderly and the very young, particularly benefit from vaccines with adjuvants because their immune systems may require an extra boost to provide protection. Adjuvants also can allow vaccine developers to use less antigen, which in some cases may be in short supply or costly. Additionally, adjuvanted vaccines can elicit more durable immune responses, reducing or eliminating the need for booster vaccinations.

 

Full Article:  https://www.niaid.nih.gov/research/vaccine-adjuvants